187 related articles for article (PubMed ID: 24500076)
1. Decreased cerebral spinal fluid neurotransmitter levels in Smith-Lemli-Opitz syndrome.
Sparks SE; Wassif CA; Goodwin H; Conley SK; Lanham DC; Kratz LE; Hyland K; Gropman A; Tierney E; Porter FD
J Inherit Metab Dis; 2014 May; 37(3):415-20. PubMed ID: 24500076
[TBL] [Abstract][Full Text] [Related]
2. Altered cerebrospinal fluid proteins in Smith-Lemli-Opitz syndrome patients.
Cologna SM; Shieh C; Toth CL; Cougnoux A; Burkert KR; Bianconi SE; Wassif CA; Porter FD
Am J Med Genet A; 2016 Aug; 170(8):2060-2068. PubMed ID: 27148958
[TBL] [Abstract][Full Text] [Related]
3. Sterol balance in the Smith-Lemli-Opitz syndrome. Reduction in whole body cholesterol synthesis and normal bile acid production.
Steiner RD; Linck LM; Flavell DP; Lin DS; Connor WE
J Lipid Res; 2000 Sep; 41(9):1437-47. PubMed ID: 10974051
[TBL] [Abstract][Full Text] [Related]
4. A Pilot Study of the Association of Markers of Cholesterol Synthesis with Disturbed Sleep in Smith-Lemli-Opitz Syndrome.
Freeman KA; Olufs E; Tudor M; Roullet JB; Steiner RD
J Dev Behav Pediatr; 2016 Jun; 37(5):424-30. PubMed ID: 27244299
[TBL] [Abstract][Full Text] [Related]
5. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
[TBL] [Abstract][Full Text] [Related]
6. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome.
Sikora DM; Pettit-Kekel K; Penfield J; Merkens LS; Steiner RD
Am J Med Genet A; 2006 Jul; 140(14):1511-8. PubMed ID: 16761297
[TBL] [Abstract][Full Text] [Related]
7. Recent insights into the Smith-Lemli-Opitz syndrome.
Yu H; Patel SB
Clin Genet; 2005 Nov; 68(5):383-91. PubMed ID: 16207203
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome.
Wassif CA; Kratz L; Sparks SE; Wheeler C; Bianconi S; Gropman A; Calis KA; Kelley RI; Tierney E; Porter FD
Genet Med; 2017 Mar; 19(3):297-305. PubMed ID: 27513191
[TBL] [Abstract][Full Text] [Related]
9. Feeding impairments associated with plasma sterols in Smith-Lemli-Opitz syndrome.
Merkens MJ; Sinden NL; Brown CD; Merkens LS; Roullet JB; Nguyen T; Steiner RD
J Pediatr; 2014 Oct; 165(4):836-41.e1. PubMed ID: 25039049
[TBL] [Abstract][Full Text] [Related]
10. Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update.
Thurm A; Tierney E; Farmer C; Albert P; Joseph L; Swedo S; Bianconi S; Bukelis I; Wheeler C; Sarphare G; Lanham D; Wassif CA; Porter FD
J Neurodev Disord; 2016; 8():12. PubMed ID: 27053961
[TBL] [Abstract][Full Text] [Related]
11. RSH/Smith-Lemli-Opitz syndrome: a multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis.
Porter FD
Mol Genet Metab; 2000; 71(1-2):163-74. PubMed ID: 11001807
[TBL] [Abstract][Full Text] [Related]
12. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
[TBL] [Abstract][Full Text] [Related]
13. Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism.
Anderson AJ; Stephan MJ; Walker WO; Kelley RI
Am J Med Genet; 1998 Aug; 78(5):413-8. PubMed ID: 9714006
[TBL] [Abstract][Full Text] [Related]
14. Generation and validation of a conditional knockout mouse model for the study of the Smith-Lemli-Opitz syndrome.
Kanuri B; Fong V; Ponny SR; Tallman KA; Rao SR; Porter N; Fliesler SJ; Patel SB
J Lipid Res; 2021; 62():100002. PubMed ID: 33410752
[TBL] [Abstract][Full Text] [Related]
15. Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.
Ginat S; Battaile KP; Battaile BC; Maslen C; Gibson KM; Steiner RD
Mol Genet Metab; 2004; 83(1-2):175-83. PubMed ID: 15464432
[TBL] [Abstract][Full Text] [Related]
16. Late endosomal/lysosomal accumulation of a neurotransmitter receptor in a cellular model of Smith-Lemli-Opitz syndrome.
Sharma A; Kumar GA; Chattopadhyay A
Traffic; 2021 Oct; 22(10):332-344. PubMed ID: 34418249
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.
Wassif CA; Maslen C; Kachilele-Linjewile S; Lin D; Linck LM; Connor WE; Steiner RD; Porter FD
Am J Hum Genet; 1998 Jul; 63(1):55-62. PubMed ID: 9634533
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism.
Narayan M; Srinath S; Anderson GM; Meundi DB
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):630-5. PubMed ID: 7687150
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D levels in Smith-Lemli-Opitz syndrome.
Movassaghi M; Bianconi S; Feinn R; Wassif CA; Porter FD
Am J Med Genet A; 2017 Oct; 173(10):2577-2583. PubMed ID: 28796426
[TBL] [Abstract][Full Text] [Related]
20. Feedback inhibition of the cholesterol biosynthetic pathway in patients with Smith-Lemli-Opitz syndrome as demonstrated by urinary mevalonate excretion.
Pappu AS; Steiner RD; Connor SL; Flavell DP; Lin DS; Hatcher L; Illingworth DR; Connor WE
J Lipid Res; 2002 Oct; 43(10):1661-9. PubMed ID: 12364550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
